Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial
| dc.contributor.author | Torp, Nikolaj | |
| dc.contributor.author | Israelsen, Mads | |
| dc.contributor.author | Coenraad, Minneke | |
| dc.contributor.author | Papp, Mária | |
| dc.contributor.author | Shawcross, Debbie L. | |
| dc.contributor.author | Korenjak, Marko | |
| dc.contributor.author | Angeli, Paolo | |
| dc.contributor.author | Laleman, Wim | |
| dc.contributor.author | Juanola, Adria | |
| dc.contributor.author | Ginès, Pere | |
| dc.contributor.author | Trebica, Jonel | |
| dc.contributor.author | Krag, Aleksander | |
| dc.contributor.author | Tornai, Dávid | |
| dc.contributor.author | Balogh, Boglárka | |
| dc.date.accessioned | 2024-01-09T09:18:04Z | |
| dc.date.available | 2024-01-09T09:18:04Z | |
| dc.date.issued | 2024 | |
| dc.date.oa | 2024-10-17 | |
| dc.date.pasync | 2025-04-15T23:08:22Z | |
| dc.date.updated | 2024-01-09T09:18:04Z | |
| dc.description.corrector | LB | |
| dc.identifier.citation | BMJ Open. -14 : 2 (2024), p. 1-8. -(cikkazonosító)e079309. -BMJ Open. - 2044-6055. - 2044-6055 | |
| dc.identifier.issn | 2044-6055 | |
| dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM117716 | |
| dc.identifier.scopus | 85185348688 | |
| dc.identifier.uri | https://hdl.handle.net/2437/364748 | |
| dc.identifier.wos | 001177385500001 | |
| dc.language | eng | |
| dc.rights.access | open access journal | |
| dc.rights.owner | szerző | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial | |
| dc.type | folyóiratcikk | |
| dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |